
Chronic Intestinal Pseudoobstruction: Understanding the Genetic Testing Pathway
Symptoms mimic a blockage although no physical obstruction exists; ACTG2 mutations affect gut smooth muscle, and testing informs diagnosis and counseling.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Symptoms mimic a blockage although no physical obstruction exists; ACTG2 mutations affect gut smooth muscle, and testing informs diagnosis and counseling.

Hypotonia, seizures and developmental delay follow when cells cannot make enough CoQ10. Recessive inheritance, DNA testing and CoQ10 supplementation are explained.

Bowel malrotation and ambiguous genitalia now join developmental delay in the COG6-CDG picture, and finding COG6 mutations allows an earlier, more certain diagnosis.

Inherited faults in the mismatch repair genes MLH1 and MSH2 sit behind this form of Lynch syndrome, so carriers can begin colonoscopy earlier and more often.

Carrying an MLH1 or MSH2 mutation raises cancer risk. Surveillance colonoscopy, lifestyle change, chemoprevention and CRISPR-Cas9n gene therapy research are set out here.

Recurrent infections, autoimmune features and a raised chance of lymphoproliferative disease follow LRBA gene mutations, which testing can identify to guide treatment.

Growth looks normal at first, then failure to thrive, psychomotor delay and severe cardiomyopathy appear as COXPD9 disrupts how cells generate energy.

Missing or faulty C4A protein weakens complement defense against infection and autoimmunity, while research also links C4A to schizophrenia and other brain conditions.